TERN

NASDAQStock

Terns Pharmaceuticals, Inc.

$44.24-2.54 (-5.43%)

52-Week Range

$2.00
$47.09

Key Stats

Market Cap

4.0B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

-0.29

Volume

1.6M

Avg Volume

2.0M

Performance

1M

+15.84%

3M

-1.69%

6M

+520.48%

YTD

+10.30%

1Y

+1108.74%

3Y

+372.15%

5Y

+78.03%

Price Chart

ETF Exposure

TERN is held by 70 ETFs

ETFFund NameWeight
SCHBSchwab U.S. Broad Market ETF0.01%
VTIVanguard Total Stock Market ETF0.01%
VTHRVanguard Russell 3000 ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
DFUSDimensional - US Equity Market ETF0.00%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
PreviousPage 2 of 2

About TERN ETF Exposure

Terns Pharmaceuticals, Inc. (TERN) is held by 70 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.0B, TERN is a widely held institutional stock. The stock currently trades at $44.24. Investors can gain exposure to TERN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TERN, sorted by portfolio weight.